Zoetis Inc.
Large Cap · Healthcare · Drug Manufacturers - Specialty & Generic
$76.60+$2.64 (+3.57%)
Zoetis Inc.
Large Cap · Healthcare · Drug Manufacturers - Specialty & Generic
$76.60+$2.64 (+3.57%)
Stock analysis
Get the AI take on ZTS
Track it to unlock the price chart, verdict and what could change it.
- ✓Live price chart
- ✓A clear accumulate, trim or avoid call
Free to track. No card required.
Stock Fundamentals & Key Indicators
52-week range
Low$71.47
High$160.48
Today $76.60
RSI (14)
41.8Neutral
03070100
Overall score
63/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
- ✓5 years of revenue, profit and cash flow
- ✓Valuation and balance-sheet checks
- ✓Business and geographic mix
- ✓Analyst targets and recommendation trend
Free for 3 days, then $9/mo. Cancel anytime.
Analyst Rating and Sentiment
Analyst price targets
Current price
$76.6
Lowest
$80
Median target
$95.5
Highest
$160
LowHigh
Operating Record
Revenue
What's working
- Forward P/E: Investors aren't pricing in much earnings growth, so there's room to be pleasantly surprised.
- Price / FCF: Real cash coming through the door backs up what you're paying.
What to watch
- Debt exceeds cash by $7.6B, increasing balance-sheet pressure, a warning sign.
- Debt / equity: Heavy borrowing means a downturn would hit harder than it otherwise would.
What the market charges
Forward P/E
Favorable · 42% below avg
11.57x
Price / sales
Reasonable · Priced reasonably against its revenue
3.20x
Price / FCF
Strong · Priced well within what its cash flow supports
13.17x
EV / EBITDA
Strong · Operating earnings comfortably support this price
9.36x
How efficiently it compounds
ROIC
Strong · Comfortably clears the bar for efficient capital use
27.3%
ROE
Favorable · 67.0% - strong capital efficiency
64.9%
Debt / equity
Needs attention · Unfavorable
2.94x
Current ratio
Strong · Comfortable room to cover bills due within a year
3.08x
Peer Comparison
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $30.49B | 12.1 | +1.6% | 63 |
 | $11.53B | 22.0 | +19.7% | 78 |
 | $4.60B | 13.9 | +13.5% | 77 |
 | $33.87B | 35.4 | +15.5% | 77 |
 | $1.11T | 40.1 | +49.6% | 76 |